Character Strengths Intervention Among Psychiatrically Hospitalized Youth

Status Completed

Clinical Trial Summary

Research has shown that identifying and using one's character strengths in new ways decreases depressive symptoms and increases happiness in adults in the general population. Recently, we found that a similar intervention increases the self-esteem and self-efficacy of children and adolescents being treated in an inpatient psychiatric unit. The purpose of this study is to better understand the effects that discovering one's character strengths and incorporating them into coping skills will have on treatment outcomes in patients admitted to a child and adolescent inpatient psychiatric unit.

Clinical Trial Description

The primary aim of this study is to investigate whether a character strengths-based intervention results in significant improvements in measures of depression, anxiety, resiliency, optimism, self-perception, and life-satisfaction of psychiatrically hospitalized youth up to three months following admission. Secondary aims are to: (1) examine participants' strengths profile to identify potential correlates between character strengths, psychiatric diagnoses and intervention effectiveness; and (2) determine whether patients who continue to incorporate their strengths into coping skills at follow-up assessments exhibit greater improvement over-time.

Participants will be 210 adolescents aged 12 to 17 years admitted to the Child and Adolescent Psychiatric Inpatient Program and will be randomized into one of the three groups. All participants will complete the Values in Action Inventory of Strengths for Youth (VIA-Youth) Survey on their second hospital day and subsequently receive the signature strengths intervention (experimental group), coping skills with memory aids comparison exercise (positive control group), or coping skills without memory aids (treatment-as-usual control group). Outcome measures will be completed by all participants at baseline (day 1 on unit), post-treatment (day 4 on unit), and 1- and 3-months following admission. The proposed research represents a change in paradigm, as we aim to specifically examine the therapeutic benefit of the positive psychology element of our intervention conducted in the pilot study among youth with severe mental illness. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02674932
Study type	Interventional
Source	University of Michigan
Contact
Status	Completed
Phase	N/A
Start date	February 2016
Completion date	December 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05321602` - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder	Phase 1
Completed	`NCT05080777` - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems	N/A
Recruiting	`NCT06012149` - Braining: Implementation of Physical Exercise for Patients in Specialist Psychiatry	N/A
Recruiting	`NCT03222375` - SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism	N/A
Active, not recruiting	`NCT02836080` - Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)	N/A
Active, not recruiting	`NCT02907658` - Efficacy of Internet Use Disorder Prevention	N/A
Completed	`NCT02710344` - Using Telehealth to Improve Psychiatric Symptom Management	N/A
Enrolling by invitation	`NCT02487888` - A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care	N/A
Recruiting	`NCT02292056` - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions	N/A
Active, not recruiting	`NCT02761733` - The Effectiveness of a Decision-Support Tool for Adult Consumers With Mental Health Needs and Their Care Managers	N/A
Completed	`NCT01947283` - Effectiveness of DECIDE in Patient-Provider Communication, Therapeutic Alliance & Care Continuation	N/A
Completed	`NCT01633138` - Performance-based Reinforcement to Enhance Cognitive Remediation Therapy	N/A
Completed	`NCT01690013` - Life Quality and Health in Patients With Klinefelter Syndrome	N/A
Completed	`NCT01656707` - Adaptive Treatment for Adolescent Cannabis Use Disorders	N/A
Completed	`NCT01415323` - Agitation in the Acute Psychiatric Department
Completed	`NCT01701765` - Outcomes and Discharge of Long-stay Psychiatric Patients	N/A
Completed	`NCT00375167` - Efficacy of the Recovery Workbook as a Psychoeducational Tool for Facilitating Recovery	N/A
Terminated	`NCT00757497` - Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia	Phase 1
Terminated	`NCT03527550` - Cognitive Control Training for Urgency in a Naturalistic Clinical Setting	N/A
Withdrawn	`NCT03518996` - Non-Invasive Brain Stimulation and Delirium	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.